M&A Deal Summary

Sinocare Acquires PTS Diagnostics

On May 2, 2016, Sinocare acquired medical products company PTS Diagnostics for 200M USD

Acquisition Highlights
  • This is Sinocare’s 2nd transaction in the Medical Products sector.
  • This is Sinocare’s 2nd largest (disclosed) transaction.
  • This is Sinocare’s 2nd transaction in the United States.
  • This is Sinocare’s 1st transaction in Indiana.

M&A Deal Summary

Date 2016-05-02
Target PTS Diagnostics
Sector Medical Products
Buyer(s) Sinocare
Deal Type Add-on Acquisition
Deal Value 200M USD
Advisor(s) J.P. Morgan Securities (Financial)

Target

PTS Diagnostics

Whitestown, Indiana, United States
PTS Diagnostics designs, manufactures, distributes and markets products for distribution. PTS Diagnostics is an innovative, global, point-of-care diagnostics solutions provider that partners with patients and healthcare professionals to provide the right information at the right time to make the right decision. PTS Diagnostics was founded in 1992 and is based in Whitestown, Indiana.

Search 215,074 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Sinocare

Changsha, China

Category Company
Founded 2002
Sector Medical Products
Employees4,809
Revenue 4.4B CNY (2024)
DESCRIPTION

Sinocare is a developer of biosensor technology. The Company promotes diabetic self-management by using blood glucose monitoring systems, providing total diabetes services and solutions. Sinocare Group was founded in 2002 and is based in Changsha, China.


DEAL STATS #
Overall 2 of 2
Sector: Medical Products M&A 2 of 2
Type: Add-on Acquisition M&A Deals 1 of 1
State: Indiana M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2016 M&A 2 of 2
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-07 Trividia Health

Fort Lauderdale, Florida, United States

Trividia Health, Inc. is a manufacturer and marketer of blood glucose monitoring products and diabetes management supplies that are available in national chains and through mail order pharmacies.

Buy $273M